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Abstract
Background: In recent decades immigration to Norway from Asia, Africa and Eastern Europe has increased rapidly. The 
aim of this study was to assess the quality of care for type 2 diabetes mellitus (T2DM) patients from these ethnic 
minority groups compared with the care received by Norwegians.
Methods: In 2006, electronic medical record data were screened at 11 practices (49 GPs; 58857 patients). 1653 T2DM 
patients cared for in general practice were identified. Ethnicity was defined as self-reported country of birth. Chi-
squared tests, one-way ANOVAs, multiple regression, linear mixed effect models and generalized linear mixed models 
were used.
Results: Diabetes was diagnosed at a younger age in patients from the ethnic minority groups (South Asians (SA): 
mean age 44.9 years, Middle East/North Africa (MENA): 47.2 years, East Asians (EA): 52.0 years, others: 49.0 years) 
compared with Norwegians (59.7 years, p < 0.001). HbA1c, systolic blood pressure (SBP) and s-cholesterol were 
measured in >85% of patients in all groups with minor differences between minority groups and Norwegians. A 
greater proportion of the minority groups were prescribed hypoglycaemic medications compared with Norwegians 
(≥79% vs. 72%, p < 0.001). After adjusting for age, gender, diabetes duration, practice and physician unit, HbA1c 
(geometric mean) for Norwegians was 6.9% compared to 7.3-7.5% in the minority groups (p < 0.05). The proportion 
with poor glycaemic control (HbA1c > 9%) was higher in minority groups (SA: 19.6%, MENA: 18.9% vs. Norwegians: 
5.6%, p < 0.001. No significant ethnic differences were found in the proportions reaching the combined target: HbA1c 
≤ 7.5%, SBP ≤ 140 mmHg, diastolic blood pressure (DBP) ≤ 85 mmHg and total s-cholesterol ≤5.0 mmol/L (Norwegians: 
25.5%, SA: 24.9%, MENA: 26.9%, EA: 26.1%, others:17.5%).
Conclusions: Mean age at the time of diagnosis of T2DM was 8-15 years younger in minority groups compared with 
Norwegians. Recording of important processes of care measures is high in all groups. Only one in four of most patient 
groups achieved all four treatment targets and prescribing habits may be sub-optimal. Patients from minority groups 
have worse glycaemic control than Norwegians which implies that it might be necessary to improve the guidelines to 
meet the needs of specific ethnic groups.
Background
In Europe ethnic differences in the prevalence of diabetes
have been described [1,2]. Ethnicity may be defined as the
social group a person belongs to because of a shared cul-
ture, history, geographical origins, language, diet, physi-
cal, genetic and other factors [3].
In the developing world, both urbanisation and a shift
towards a westernised lifestyle are risk factors for devel-
oping type 2 diabetes mellitus (T2DM). Immigrants from
Asia and Africa living in Europe also have different diabe-
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tes characteristics than Europeans [4]. Inherited insulin
resistance, low birth weight, migration itself as well as
lifestyle, cultural and socioeconomic factors may contrib-
ute to the observed differences [5-7].
In T2DM, a long-term, intensified intervention target-
ing multiple risk factors is crucial for reducing cardiovas-
cular death rates and micro-vascular complications [8,9].
Across Europe, the structure of care for T2DM varies by
country, from mainly hospital based to mainly general
practitioner (GP) based [10].
During the last three decades, immigration to Norway
from Asia, Africa, Eastern Europe and Central- and
South America has increased rapidly. In 2005 ethnic
groups with origin from these regions (first and second
generation) accounted for approximately 18% of the pop-
ulation in Oslo [11].
Socioeconomic status, chronic illnesses and risk factors
for diabetes (e.g., obesity and physical inactivity), and the
use of health care services differ between and within
these groups [12]. In 2000, an alarmingly high prevalence
of diabetes was found among 30-59 year old South Asians
compared with Norwegians, 14.3% vs. 5.9% in men and
27.5% vs. 2.9% in women [13].
In Norway, the majority of T2DM patients are cared for
in general practice whereas type 1 diabetes mellitus
(T1DM) patients usually receive hospital based specialist
care. In general, the quality of care for T2DM has
improved since 1995 [14,15]. However, little is known
about the ability of GPs to adapt their clinical practice to
provide optimal health care for all diabetic patients irre-
spective of their ethnic origin.
The aim of this study was to assess the quality of care
for different ethnic minority patient groups with T2DM
treated in general practice in Oslo and to compare it with
the quality of care received by Norwegians.
Methods
Design, participants and setting
T h i s  s t u d y  i s  b a s e d  o n  t h e  O s l o  d a t a  s u b s e t  f r o m  a
national cross-sectional study assessing the quality of dia-
betes care in general practice [14]. In 2006 retrospective
data were captured from electronic medical records
(EMR) in practices in four areas in Norway. 17 practices
located in a suburb in eastern Oslo where 31% of the pop-
ulation are ethnic minorities [11] were invited to partici-
pate in this study. 14 practices accepted the invitation and
11 took part in the study. Of the three practices accepting
but not participating, one could not participate due to
problems with the EMR system and two small practices
were not included due to shortage of funding. The data
used in this study are therefore based on 11 practices (49
GPs, 58857 patients).
A software program designed for the study (Mediata
AS, Norway) was used to identify patients with diabetes
and to capture predefined data from the GPs' EMR (from
2003 to 2005).
In total, 2064 patients with a diabetes diagnosis were
identified. For each identified patient, data was manually
checked by an experienced research nurse (WI) to iden-
tify patients who met our inclusion criteria. Because the
study addressed quality of care in general practice for
T2DM patients, we excluded patients with T1DM,
patients with T2DM who had two or more visits in hospi-
tal clinics for diabetes care in the previous 12 months,
those who had less than six months of follow-up, those
who had moved, were deceased, or had missing data
regarding country of birth.
The study was approved by the Regional ethics board
for biomedical research, the Directorate for Health and
Social Affairs and the Data Inspectorate.
Variables
Ethnicity was based on self-reported country of birth, as
noted in the EMR. Included patients were categorized as
follows: Norwegians (including ≈2% Scandinavians and
others from Western Europe/North America), South
Asians (SA; ≈75% Pakistanis, ≈25% Sri Lankans and a few
Indians), Middle East/North Africans (MENA; mainly
from Turkey and Morocco), East Asians (EA; mainly from
Vietnam), and others (O; from Eastern Europe, South
Sahara Africa, Central- and South America), with all
except those categorized as Norwegians are referred to as
ethnic minorities.
Demographic characteristics and data on processes of
care, intermediate outcomes of care and prescriptions for
oral hypoglycaemic agents (OHAs), insulin, anti-hyper-
tensive- or statin therapy were recorded. Processes of
care data include whether or not a recommended mea-
surement/examination such as HbA1c, systolic blood
pressure (SBP), diastolic blood pressure (DBP), s-choles-
terol, microalbuminuria, referral to ophthalmologist,
foot-examination, smoking habits, body height and body
weight had been performed in the defined period. Inter-
mediate outcomes were recorded results of particular
measurements or examinations. Data regarding HbA1c,
SBP, DBP, microalbuminuria, body weight and foot-
examinations were from 2005, data for eye examinations
from 2004 or 2005, and for s-cholesterol and smoking
habits from the years 2003 to 2005. National guidelines
recommend that these measures should be performed on
a regular basis [16]. The most recent result was chosen if
more than one value was available.
The treatment targets used in this study were: HbA1c ≤
7.5%, SBP ≤ 140 mmHg, DBP ≤ 85 mmHg, and total s-
cholesterol ≤ 5.0 mmol/L [14,15].Tran et al. BMC Health Services Research 2010, 10:145
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Statistical analyses
Patient's age when the diabetes diagnosis was established,
was estimated based on data regarding disease duration.
Chi-squared tests were applied for testing differences
between proportions in the ethnic groups. Differences in
mean values for the continuous variables between the
ethnic groups were tested by one-way ANOVAs. Multiple
regression models were applied to estimate ratios of geo-
metric means and mean differences for the continuous
variables in the particular group compared with the refer-
ence group (Norwegians). Random intercept models
were used for adjustment for physicians and practices.
Physicians and practices were specified as random and
fixed effect variables correspondingly in linear mixed
effect models (lme) and generalized linear mixed models
(glmmML). The lme and glmmML functions were used
for continuous and binary dependent variables respec-
tively.
Because the data were highly skewed, HbA1c values
were log-transformed before applying the random inter-
cept model, and the results (estimates with 95% confi-
dence intervals) were transformed back to the original
scale using anti-log. HbA1c (geometric mean) was used
for comparison between groups.
Two-sided tests were used, and p-values were not cor-
rected for multiple testing.
The analyses were performed with R 2.8.1 [17] and
SPSS 15.0 for Windows. The lme and glmmML functions
were from the nlme and glmmML packages in R.
Results
We identified 2064 patients with diabetes from 58857
EMR. A total of 411 patients were excluded (264 had two
or more visits in hospital based care the previous year,
128 had moved, were deceased or for other reasons had
less than 6 months follow-up in the practice, 17 had
T1DM and there were missing data on country oft birth
in two patients).
Of the 1653 included T2DM patients, 68.5% were clas-
sified as Norwegians and 31.5% were ethnic minorities
(Table 1). The groups differed significantly for mean age,
age at diagnosis, and body mass index (BMI) (Table 1).
Among patients with body height and weight recorded,
46% of Norwegians, 43% of SA, 60% of MENA, 17% of EA
and 41% of patients from other regions had BMI ≥ 30 kg/
m2. When applying the definition of obesity in Asians as
suggested by WHO, 81.4% of SA and 73.9% of EA had
BMI ≥ 25 kg/m2 [18].
Processes of care
In all groups, 85-97% had their HbA1c, SBP and s-choles-
terol measured, 34-50% had their microalbuminuria
assessed, and 50-63% had been referred to an ophthal-
mologist. Foot assessment was recorded in less than 20%
(Table 2). Blood pressure (BP) and smoking habits were
recorded significantly less often whereas s-cholesterol
level was measured more often in the ethnic minorities
compared with Norwegians.
Medication use and intermediate outcomes
OHAs alone or in combination with insulin were pre-
scribed more often to ethnic minorities (SA: 84%, MENA:
79%, EA: 80%, other regions: 81%) than in Norwegians
(72%) (Table 3). Compared with SA, almost twice as
many Norwegians were not prescribed any hypoglycae-
mic agent (p < 0.001).
HbA1c (geometric mean) was 6.9% in Norwegians and
7.1 to 7.6% in the minority groups. After adjustments for
confounders, i.e. age, gender, diabetes duration and clus-
tering variables, i.e. practice unit and physician unit all
the ethnic minority groups had significantly higher mean
levels of HbA1c (7.3-7.5%) compared to Norwegians
(6.9%), p < 0.05 (Table 4). Diabetes duration and practice
were significant predictors for HbA1c.
Fewer in the ethnic minority groups were prescribed
anti-hypertensive agents or statins (p < 0.001) (Table 3).
SA had lower SBP and DBP values than Norwegians
(Table 4). The differences remained significant after
adjustments for confounders as well as after additional
adjustment for clustering. Only EA had significantly
higher s-cholesterol compared with Norwegians after
adjustments for confounders and clustering.
Achievement of national targets
While 72.6% of Norwegians had HbA1c ≤ 7.5%, the corre-
sponding proportion varied from 56.1% to 71.2% in the
minority groups (p < 0.001 for between group differ-
ences) (Figure 1 and Table 5).
Poor glycaemic control (HbA1c > 9.0%) was three times
more prevalent among patients from SA (19.6%), from
MENA (18.9%) and from other regions (17.5%) than in
Norwegians (5.9%), (p < 0.001). An exception was
p a t i e n t s  f r o m  E A ,  w h e r e  o n l y  3 . 8 %  h a d  p o o r  c o n t r o l .
When including the treatment targets for SBP, DBP and
serum cholesterol, 17.5 to 26.9% of all groups had reached
all four targets (Table 5).
Compared with Norwegian patients odds ratio (OR) for
achieving good glycaemic control (HbA1c ≤ 7.5%)
adjusted for confounders and clustering was reduced in
all ethnic minority groups (SA: 0.6 (0.5 to 0.9), MENA: 0.6
(0.4 to 1.1) EA: 0.7 (0.3 to 1.4), O: 0.6 (0.3 to 1.1)). Com-
pared with the Norwegian group only the O group had a
significantly reduced OR for achieving the combined (all-
four) target adjusted for the same factors (SA: 0.8 (0.5 to
1.1), MENA: 0.7 (0.4 to 1.3) EA 0.6 (0.3 to 1.4), O 0.4 (0.2
to 0.9).Tran et al. BMC Health Services Research 2010, 10:145
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Discussion
This is the first Norwegian study assessing quality of care
parameters in patients with T2DM treated in general
practice according to their ethnic background. In general,
the GPs performed the recommended measures at com-
parable rates in both Norwegians and ethnic minority
patients. However, in all minority groups the glycaemic
control was poorer than in Norwegians (adjusted geo-
metric mean HbA1c 0.4-0.6% higher) despite more inten-
sive treatment with OHAs and/or insulin. A younger age
at time of diagnosis (8-15 years) was found in the ethnic
minority groups.
Ethnic minority groups accounted for 32% of the
patients with T2DM, a figure that is very similar to the
percentage of ethnic minorities in the background popu-
lation in the area (31%) [11]. We found a prevalence of
T2DM for the population >20 years of age of 4.6% and for
the total study population of 3.5%. This corresponds well
with earlier studies from the same area with 4.1% (age
group 30-67 years of age) reporting known diabetes in
2000 [13]. The prevalence may appear to be lower than
expected in a multiethnic population, but the young age
of the ethnic minority population must be taken into
account. We thus consider the study population to be
fairly representative of the suburban area in eastern Oslo.
The list based practice system allows us to trace patients
and ensures that there are no duplicates. Manual verifica-
tion of the electronically extracted data by one experi-
enced nurse contributes to the internal validity of this
study.
The younger age at diagnosis in the minority groups
compared with Norwegians, indicates that the
pathophysiological processes of T2DM start or accelerate
earlier. The difference in age at diagnosis between SA and
the majority population was even larger in our study (15
years) than in two studies from the UK (11 and 5 years
respectively) [19,20].
The quality of care in terms of processes of care was
comparable to that found in other Norwegian regions and
i n  t h e  U K  [ 1 4 , 2 1 ] .  H b A 1 c ,  B P  a n d  s - c h o l e s t e r o l  w e r e
measured in the majority of patients in nearly all groups
as recommended by the national guidelines. These results
Table 1: Characteristics of patients (n = 1653) with type 2 diabetes mellitus by ethnic background.
Characteristics All (n = 1653) Norwegians 
(n = 1129)
South Asians
 (n = 322)
MENAa (n = 81) East Asians 
(n = 54)
Othersb 
(n = 67)
Pc
Males (n=) 828 564 160 42 21 41 0.19
Age
Valid cases (n=) 1653 1129 322 81 54 67
Mean (year) 66.4 52.3 53.1 57.7 56.6 <0.001
95% CI 65.7 to 67.2 51.2 to 53.3 50.9 to 55.3 54.9 to 60.6 53.6 to 59.6
Age at diagnosis
Valid cases (n=) 1526 1061 292 71 44 58
Mean (year) 59.7 44.9 47.2 52.0 49.0 <0.001
95% CI 58.9 to 60.5 43.8 to 46.0 44.8 to 49.6 48.4 to 55.5 45.9 to 52.1
Diabetes duration
Valid cases (n=) 1526 1061 292 71 44 58
Mean (year) 6.6 7.0 5.5 5.0 6.4 0.11
95% CI 6.2 to 6.9 6.3 to 7.7 4.4 to 6.7 3.8 to 6.1 5.0 to 7.8
Body Mass Index
Valid cases (n=) 723 501 140 37 23 22
Mean (kg/m2) 30.1 29.8 31.9 27.5 29.1 <0.001
95% CI 29.6 to 30.6 29.0 to 30.7 29.4 to 34.4 26.0 to 28.9 26.6 to 31.6
a Patients from Middle East/North Africa.
b Patients from other regions.
c p-values. One-way ANOVAs were applied to compare mean age, diabetes duration, age at diagnosis and BMI between ethnic groups. Chi-square 
test was applied to compare percentage of males between ethnic groups.Tran et al. BMC Health Services Research 2010, 10:145
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Table 2: Proportions (%) of patients with important processes of care recorded in electronic medical records.
Features recorded 
in EMR
All (n = 1653) Norwegians 
(n = 1129)
South Asians 
(n = 322)
MENAa (n = 81) East Asians 
(n = 54)
Othersb 
(n = 67)
pc
HbA1c 94.7 95.2 93.5 91.4 96.3 94.0 0.45
Systolic blood 
pressure
90.6 92.5 85.7 87.7 85.2 91.0 0.003
S-Cholesterol 94.2 92.3 96.9 95.1 94.4 97.0 0.03
Micro-albuminuria 46.2 46.8 46.9 43.2 50.0 34.3 0.33
Reference to 
ophthalmologist
60.3 60.4 63.4 49.5 59.3 58.2 0.25
Foot examination 18.0 18.7 18.0 14.8 11.1 14.9 0.54
Smoking habits 59.4 64.0 53.4 42.0 46.3 43.3 <0.001
Body height 47.1 47.5 46.3 53.1 48.1 35.8 0.31
Body weight 56.1 56.8 57.8 53.1 50.0 46.3 0.37
a Patients from Middle East/North Africa.
b Patients from other regions.
c p-values. Chi-squared tests were applied to identify differences between ethnic groups with recorded measurement.
Table 3: Proportions (%) of patients receiving hypoglycaemic, anti-hypertensive and statin therapy.
Treatment groups All (n = 1653) Norwegians 
(n = 1129)
South Asians 
(n = 322)
MENAa (n = 81) East Asians 
(n = 54)
Othersb 
(n = 67)
Pc
Diet alone 24.7 27.9 16.1 21.0 20.4 19.4 <0.001
Oral agents 56.1 54.8 57.8 61.7 61.1 58.2 0.19
Insulin and oral 
agents
9.5 7.5 16.1 7.4 5.6 16.4 0.001
Insulin alone 9.7 9.7 9.9 9.9 13.0 6.0 0.66
Anti-hypertensive 
therapy
61.1 69.4 43.2 34.6 44.4 53.7 <0.001
Statin therapy 39.0 42.8 35.7 24.7 22.2 22.4 <0.001
a Patients from Middle East/North Africa.
b Patients from other regions.
c p-values. Chi-squared tests were applied to identify differences between ethnic groups receiving treatment.Tran et al. BMC Health Services Research 2010, 10:145
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Table 4: Crude and adjusted means with 95% CIs for risk factors in five patient groups.
Variablea Ethnic 
groups b
Unadjustedd Adjusted g Adjustedh
Meanc Ratio/Differencee 
(95% CI)
P f Meanc Ratio/Differencee 
(95% CI)
P f Meanc Ratio/Differencee 
(95% CI)
P f
HbA1c (%)
Nor 6.91 Ref. 6.89 Ref 6.94 Ref
SA 7.55 1.09 (1.07 to 1.12) <0.001 7.47 1.08 (1.06 to 1.11) <0.001 7.46 1.07 (1.05 to 1.10) <0.001
MENA 7.08 1.03 (0.99 to 1.07) 0.195 7.14 1.04 (1.00 to 1.10) 0.086 7.32 1.05 (1.01 to 1.10) 0.008
EA 7.15 1.04 (0.99 to 1.08) 0.120 7.28 1.06 (1.01 to 1.11) 0.026 7.38 1.06 (1.01 to 1.11) 0.011
Others 7.33 1.06 (1.02 to 1.11) 0.004 7.31 1.06 (1.02 to 1.11) 0.007 7.33 1.06 (1.01 to 1.10) 0.011
SBP 
(mmHg)
Nor 138.9 Ref 137.5 Ref 137.8 Ref
SA 126.7 -12.2 (-14.5 to -10.0) <0.001 130.7 -6.8 (-9.4 to -4.3) <0.001 131.0 -6.8 (-9.4 to -4.2) <0.001
MENA 128.4 -10.5 (-14.6 to - 6.3) <0.001 132.2 -5.3 (-9.6 to -1.0) 0.015 132.8 -5.0 (-9.3 to -0.6) 0.024
EA 132.7 -6.2 (- 11.3 to -1.2) 0.016 137.0 -0.6 (-6.1 to 5.0) 0.842 137.9 0.1 (-5.5 to 5.6) 0.981
Others 131.1 -7.8 (-12.2 to -3.4) 0.001 134.4 -3.2 (-7.8 to 1.5) 0.181 135.5 -2.3 (-6.9 to 2.4) 0.340
DBP 
(mmHg)
Nor 79.6 Ref 80.2 Ref 80.2 Ref
SA 76.7 -2.9 (-4.1 to -1.6) <0.001 75.8 -4.3 (-5.7 to -2.9) <0.001 76.2 -4.0 (-5.4 to -2.5) <0.001
MENA 76.6 -3.0 (-5.2 to -0.8) 0.008 75.3 -4.8 (-7.2 to -2.5) <0.001 75.8 -4.4 (-6.7 to -2.0) <0.001
EA 80.4 0.8 (-2.0 to 3.5) 0.579 80.8 0.6 (-2.5 to 3.6) 0.709 81.4 1.2 (-1.8 to 4.2) 0.430
Others 76.0 -3.6 (-5.9 to -1.2) 0.004 75.5 -4.6 (-7.2 to -2.1) <0.001 76.5 -3.7 (-6.3 to -1.2) 0.004
S-Chol 
(mmol/L)
Nor 5.15 Ref 5.11 Ref 5.14 Ref
SA 4.92 -0.22 (-0.36 to -0.09) 0.001 5.00 -0.12 (-0.27 to 0.04) 0.139 5.06 -0.08 (-0.24 to 0.08) 0.313
MENA 5.15 0.01 (-0.24 to 0.25) 0.962 5.14 0.03 (-0.23 to 0.29) 0.823 5.23 0.09 (-0.18 to 0.35) 0.526
EA 5.40 0.25 (-0.05 to 0.55) 0.099 5.45 0.33 (0.01 to 0.66) 0.046 5.51 0.37 (0.04 to 0.70) 0.026
Others 5.14 -0.01 (-0.27 to 0.26) 0.652 5.16 0.05 (-0.23 to 0.33) 0.725 5.20 0.06 (-0.23 to 0.34) 0.702
a HbA1c was log-transformed before applying the random intercept model for estimation due to highly skewed distribution of data. The results 
(estimates with 95% confidence intervals) were transformed back to the original scale using anti-log. SBP: systolic blood pressure; DBP: diastolic 
blood pressure; S-Chol: S-Cholesterol.
b Nor: Norwegians; SA: South Asians, MENA: patients from Middle East/North Africa, EA: East Asians, Others: patients from other regions.
c Geometric means of HbA1c and arithmetic means of SBP, DBP and S-Cholesterol.
d Multiple regression models were applied to estimate difference in the particular group compared to the reference group (Norwegians).
e The antilog of the effect of the ethnic group on HbA1c is the ratio of geometric means between the particular group and the reference group 
(Norwegians).
f p-values.
g Multiple regression models were applied to estimate difference in the particular group compared to reference group (Norwegians) adjusted for 
confounders (age, gender, diabetes duration).
h Linear mixed effect models (lme in R [17]) were applied to estimate difference in the particular group compared to reference group (Norwegians) 
adjusted for confounders (age, gender, diabetes duration), practices and physicians (as random intercept).Tran et al. BMC Health Services Research 2010, 10:145
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may reflect a relatively well-developed health care sys-
tem, implying equal access to the public health service for
all and a personal GP for everyone according to a list
based system.
However, disparities in intermediate outcomes such as
HbA1c appear to be more difficult to eliminate. Differ-
ences in metabolic and lifestyle factors like degree of
insulin resistance, physical inactivity and diet together
with compliance with prescribed antihyperglycaemic
medication, may contribute [22,23]. In addition to ethnic-
ity and diabetes duration the practice unit was a signifi-
cant parameter in the final model of the multiple
regression analyses and organisational matters like the
staffing of practices and lack of effective cooperation
between GPs and secondary care may contribute to
poorer diabetes control in the ethnic minority groups.
Language barriers and cultural factors affecting disease
perceptions and the ability to cope with the self-manage-
ment strategy of diabetes care, may also have contributed
to the observed differences in the intermediate outcomes
[24].
The ethnic differences in glycaemic control, especially
between SA and Norwegians were comparable to corre-
sponding reports from the UK [19,20,25]. Although SA
have lower mean SBP and DBP compared to Norwegians,
the GPs should pay particular attention to this ethnic
group because of their higher risk for coronary heart dis-
ease [5,20].
In our study, only one out of four in most groups
reached the combined goals for glycaemia, SBP, DBP and
lipid control although a larger proportion of the minority
groups achieved the treatment target for SBP [26].
After implementation of pay-for-performance in the
UK, the proportion of diabetic patients reaching treat-
ment target for HbA1c, BP and total cholesterol
increased across the ethnic groups. However, poorer gly-
caemic control in South Asian and black African and
black Caribbean groups persisted relative to the white
British group [27].
In Norway, the high level of performed measurements
for HbA1c, SBP and s-cholesterol and the similar inter-
mediate outcomes were achieved without specific finan-
Table 5: Proportions (%) reaching national treatment goals in five patient groups.
Treatment 
targets
All (n = 1653) Norwegians 
(n = 1129)
South Asians 
(n = 322)
MENAb (n = 81) East Asians 
(n = 54)
Othersc (n = 67) Pd
HbA1c (≤7.5%) 68.6 72.6 56.1 68.9 71.2 58.7 <0.001
SBPa (≤140 
mmHg)
69.6 63.6 86.2 80.3 71.7 82.0 <0.001
DBPa (≤85 
mmHg)
80.6 79.0 84.7 87.3 73.9 86.9 0.048
S-Cholesterol 
(≤5.0 mmol/L)
49.7 49.3 55.1 44.2 35.3 47.7 0.061
All four targets 25.1 25.5 24.9 26.9 26.1 17.5 0.77
a SBP: systolic blood pressure; DBP: diastolic blood pressure.
b Patients from Middle East/North Africa.
c Patients from other regions.
d p-values. Chi-squared tests were applied to identify differences between ethnic groups achieving the national targets.
Figure 1 Achievement (% with 95% CI) of national target for 
HbA1c (≤7.5%) by ethnicity. a Nor = Norwegians; SA = South Asians; 
MENA = Middle East/North Africa; EA = East Asia; Others = patients 
from other regions.
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cial incentives. In 2008, a small additional payment for
using an annual structured electronic diabetes control
form was introduced [28] which may stimulate the GPs to
follow the guidelines and thereby improve the quality of
diabetes care in the long term. Nevertheless it is essential
to monitor the ethnic disparities in intermediate out-
comes for diabetes over time [29].
Limitations
The study has limitations due to the small sample size for
some of the groups and the heterogeneity within groups.
Furthermore we lack potential important information
on socioeconomic status at the individual level. We do
not have data to explore the reasons for poor glycaemic
c o n t r o l  i n  t h e  m i n o ri t y  gr o u ps,  s u c h  as  c o m p l ia n c e  t o
prescribed medication and the impact of language barri-
ers.
Our data do not allow us to estimate the T2DM preva-
lence in the different ethnic groups.
The cross-sectional design implies that we have not
studied in the influence of ethnicity on process of care or
intermediate outcome over time.
Conclusion
Our findings show that GPs in eastern Oslo deliver com-
parable quality of diabetes care to all ethnic patient
groups with respect to process measures.
However, this study has identified important challenges
in the treatment of hyperglycaemia in the minority
groups. The early onset of T2DM and the poor glycaemic
control of relatively young ethnic minority patients repre-
sent a major concern. It underlines the need for early
diagnosis, a tight follow-up of ethnic minority T2DM
patients and a tailored collaboration between GPs and
diabetic specialists for patients who do not achieve treat-
ment goals [30,31].
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